GB0506562D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0506562D0
GB0506562D0 GBGB0506562.8A GB0506562A GB0506562D0 GB 0506562 D0 GB0506562 D0 GB 0506562D0 GB 0506562 A GB0506562 A GB 0506562A GB 0506562 D0 GB0506562 D0 GB 0506562D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0506562.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0506562.8A priority Critical patent/GB0506562D0/en
Publication of GB0506562D0 publication Critical patent/GB0506562D0/en
Priority to PCT/EP2006/002953 priority patent/WO2006103088A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D515/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0506562.8A 2005-03-31 2005-03-31 Novel compounds Ceased GB0506562D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0506562.8A GB0506562D0 (en) 2005-03-31 2005-03-31 Novel compounds
PCT/EP2006/002953 WO2006103088A1 (en) 2005-03-31 2006-03-29 Novel hydroxyethylamine and ketone compounds having asp2 inhibitory activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0506562.8A GB0506562D0 (en) 2005-03-31 2005-03-31 Novel compounds

Publications (1)

Publication Number Publication Date
GB0506562D0 true GB0506562D0 (en) 2005-05-04

Family

ID=34566776

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0506562.8A Ceased GB0506562D0 (en) 2005-03-31 2005-03-31 Novel compounds

Country Status (2)

Country Link
GB (1) GB0506562D0 (en)
WO (1) WO2006103088A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2185561E (en) * 2007-07-27 2011-09-07 Sanofi Aventis 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo(1,2-a)-diazepine-7-carboxamide derivatives, preparation and therapeutic use thereof
FR2919285B1 (en) 2007-07-27 2012-08-31 Sanofi Aventis 1-OXO-ISOINDOLINE-4-CARBOXAMIDE AND 1-OXO-1,2,3,4-TETRAHYDROISOQUINOLEINE-5-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
FR2919286A1 (en) 2007-07-27 2009-01-30 Sanofi Aventis Sa New dihydroquinazoline- or dihydroisoquinoline carboxamide compounds are beta-secretase inhibitors useful to treat e.g. senile dementia, mild cognitive disorder, Huntington disease, Creutzfeldt-Jakob disease, migraine and anxiety
FR2919288B1 (en) * 2007-07-27 2009-09-04 Sanofi Aventis Sa 1,2,3,4-TETRAHYDROPYRROLO [1,2-A] PYRAZINE-6-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
FR2919289B1 (en) * 2007-07-27 2009-09-04 Sanofi Aventis Sa 2,3,4,5-TETRAHYDROPYRROLO [1,2-A] [1,4] -DIAZEPIN-7-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE.
CN102344485A (en) * 2010-08-05 2012-02-08 中国人民解放军军事医学科学院毒物药物研究所 Peptide beta secretase inhibitor for treating alzheimer's disease, and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE314343T1 (en) * 2000-06-30 2006-01-15 Elan Pharm Inc COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
GB0305918D0 (en) * 2003-03-14 2003-04-23 Glaxo Group Ltd Novel compounds
GB0309221D0 (en) * 2003-04-23 2003-06-04 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
WO2006103088A1 (en) 2006-10-05

Similar Documents

Publication Publication Date Title
AP2007004171A0 (en) Novel compounds
EP1868612A4 (en) Novel compounds
GB0503955D0 (en) Novel compounds
GB0506562D0 (en) Novel compounds
EP1869026A4 (en) Novel compounds
GB0500140D0 (en) Novel compounds
GB0503127D0 (en) Novel compounds
GB0503122D0 (en) Novel compounds
GB0504098D0 (en) Novel compounds
GB0504097D0 (en) Novel compounds
GB0500282D0 (en) Novel compounds
GB0500284D0 (en) Novel compounds
GB0504095D0 (en) Novel compounds
GB0503155D0 (en) Novel compounds
GB0503142D0 (en) Novel compounds
GB0503135D0 (en) Novel compounds
GB0503134D0 (en) Novel compounds
GB0503133D0 (en) Novel compounds
GB0503132D0 (en) Novel compounds
GB0503131D0 (en) Novel compounds
GB0500285D0 (en) Novel compounds
GB0503130D0 (en) Novel compounds
GB0503129D0 (en) Novel compounds
GB0504099D0 (en) Novel compounds
GB0503126D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)